GSK plc
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GLAXF | MRK | GILD | PFE | SNY | 014570.KQ | |
|---|---|---|---|---|---|---|
| Market cap | 96.21B | 370.96B | 216.41B | 175.50B | 113.74B | 30.31B |
| P/E (TTM) | 16.8 | 151.9 | — | 44.0 | 23.6 | — |
| Forward P/E | 10.9 | 16.7 | 17.3 | 10.6 | 8.9 | — |
| Price/book | 3.8 | 8.9 | 16.6 | 2.1 | 1.4 | — |
| Dividend yield | 3.80% | 2.26% | 1.88% | 5.59% | 5.10% | 6.41% |
| 1-year change | +13.07% | +75.29% | +41.39% | +23.90% | −4.08% | −33.80% |
| Today | −2.68% | +3.93% | +4.19% | +2.63% | +4.72% | −0.36% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All GLAXF news ›Wolfe Research initiated coverage on GSK plc with a new price target
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Wolfe Research initiated coverage…
GSK plc downgraded by Jefferies with a new price target
Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. GSK plc downgraded by Jefferies…
Viola Davis partners with GSK to educate adults 50 and older about their shingles risk
For the first time, Viola Davis shares her experience with shinglesViola encourages adults 50 years and older to prioritize their health and have candid conversations about increased risks that come with agingThe partnership is part of…
EnteroBiotix appoints former GSK Chief Medical Officer to board
EnteroBiotix has appointed Dr Murray Stewart, former Chief Medical Officer at GSK and Rhythm Pharmaceuticals, to its Board of Directors. Stewart has also served as Head of Research and Development at Novelion Therapeutics. During his time…
GSK Pharma posts 30.44 pc rise in net profit to Rs 336 cr in Q2
New Delhi, Aug 3 (PTI) GlaxoSmithKline Pharmaceuticals Ltd on Tuesday reported a 30.44 per cent rise in consolidated net profit to Rs 335.88 crore in the September quarter, driven by strong growth in sales across verticals. The pharma…
Q2 results, Nov 3: SBI, NSE, Bajaj Finserv, Solar Industries, Lupin, MCX, Graphite India, Gujarat Fluorochemicals, GSK, others to post earnings
Upstox - Q2 results, Nov 3: SBI, NSE, Bajaj Finserv, Solar Industries, Lupin, MCX, Graphite India, Gujarat Fluorochemicals, GSK, others to post earnings Na
Convatec hires former Fortrea, Labcorp and GSK exec as CFO
Published on 11/03/2026 at 05:00 am EST Additionally on Tuesday, Convatec promotes Brian May to senior independent director, succeeding Margaret Ewing, who will remain on the board until the company's next annual general meeting, which it…
GSK’s Positive Cancer Trial Results Reveal Oncology Momentum
GSK’s oncology division is riding strong tailwinds after publishing a series of impressive clinical trial results throughout October 2026. In the build-up to the ESMO 2026 (European Society of Medical Oncology) conference in Madrid, Spain,…
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients
PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an alternative to chemotherapy,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com66
- seekingalpha.com15
- stocktitan.net11
- quantisnow.com6
- themarketsdaily.com6
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.